Givaudan H1 free cash flow turns negative despite 6.3% sales growth

Givaudan reported robust H1 2025 operational performance, with like-for-like sales up 6.3% to CHF 3.86 billion and improved EBITDA and operating margins. However, the Swiss fragrance company experienced a significant deterioration in free cash flow, turning negative CHF 16 million from a positive CHF 197 million in H1 2024, which it attributed to timing effects related to investments and tax payments. This sharp decline in cash generation, alongside an increase in net debt, presents a notable concern despite the otherwise strong top-line growth and profitability metrics.

Analysis

Givaudan's first-half 2025 results present a bifurcated performance, characterized by strong operational growth juxtaposed with a severe deterioration in cash generation. The company reported robust like-for-like sales growth of 6.3% to CHF 3.86 billion, exceeding its 4-5% long-term target, driven by an 8.6% LFL increase in the high-margin Fragrance & Beauty segment. Profitability metrics also improved, with the comparable EBITDA margin expanding to 25.2% from 24.8% and gross margin remaining stable at 44.0% despite higher input costs, indicating successful price increases. However, this operational strength is overshadowed by a significant decline in free cash flow, which turned negative to CHF -16 million from a positive CHF 197 million in the prior-year period. The company attributes this to timing effects from investments and tax payments, a claim that warrants scrutiny given the magnitude of the drop and its stark contrast to the five-year target of at least 12% FCF as a percentage of sales. Consequently, net debt increased to CHF 4.49 billion, though the net debt to EBITDA ratio improved year-over-year to 2.5 due to strong earnings growth.

Key Decisions for Investors

• Investors should critically assess management's explanation for the negative free cash flow, as its recovery is crucial for justifying the company's valuation and meeting its long-term guidance.
• Monitor the sustainability of pricing power, as stable gross margins were achieved by passing on costs to customers, and watch for any further margin compression in segments like Fragrance & Beauty, where the reported EBITDA margin declined.
• Consider the current operational momentum a key positive, but weigh it against the significant cash flow and balance sheet risks, suggesting a hold position until there is greater clarity on the normalization of cash conversion.